Literature DB >> 11748254

The central role of SOCS-3 in integrating the neuro-immunoendocrine interface.

C J Auernhammer1, S Melmed.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11748254      PMCID： PMC209479          DOI： 10.1172/JCI14662

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  53 in total

Review 1.  gp130 cytokine signaling in the pituitary gland: a paradigm for cytokine-neuro-endocrine pathways.

Authors:  E Arzt
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

2.  Twenty proteins containing a C-terminal SOCS box form five structural classes.

Authors:  D J Hilton; R T Richardson; W S Alexander; E M Viney; T A Willson; N S Sprigg; R Starr; S E Nicholson; D Metcalf; N A Nicola
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

3.  Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response.

Authors:  V Chesnokova; C J Auernhammer; S Melmed
Journal:  Endocrinology       Date:  1998-05       Impact factor: 4.736

4.  Leukemia inhibitory factor modulates interleukin-1beta-induced activation of the hypothalamo-pituitary-adrenal axis.

Authors:  C J Auernhammer; V Chesnokova; S Melmed
Journal:  Endocrinology       Date:  1998-05       Impact factor: 4.736

5.  Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction.

Authors:  S E Nicholson; T A Willson; A Farley; R Starr; J G Zhang; M Baca; W S Alexander; D Metcalf; D J Hilton; N A Nicola
Journal:  EMBO J       Date:  1999-01-15       Impact factor: 11.598

6.  The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities.

Authors:  M M Song; K Shuai
Journal:  J Biol Chem       Date:  1998-12-25       Impact factor: 5.157

7.  Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.

Authors:  C J Auernhammer; V Chesnokova; C Bousquet; S Melmed
Journal:  Mol Endocrinol       Date:  1998-07

8.  A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B.

Authors:  F Verdier; R Rabionet; F Gouilleux; C Beisenherz-Huss; P Varlet; O Muller; P Mayeux; C Lacombe; S Gisselbrecht; S Chretien
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

9.  Pituitary-directed leukemia inhibitory factor transgene causes Cushing's syndrome: neuro-immune-endocrine modulation of pituitary development.

Authors:  H Yano; C Readhead; M Nakashima; S G Ren; S Melmed
Journal:  Mol Endocrinol       Date:  1998-11

10.  Identification of SOCS-3 as a potential mediator of central leptin resistance.

Authors:  C Bjørbaek; J K Elmquist; J D Frantz; S E Shoelson; J S Flier
Journal:  Mol Cell       Date:  1998-03       Impact factor: 17.970
View more
  16 in total

1.  Putting the brakes on arthritis: can suppressors of cytokine signaling (SOCS) suppress rheumatoid arthritis?

Authors:  R Rottapel
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

Review 2.  gp130 cytokine signaling in the pituitary gland: a paradigm for cytokine-neuro-endocrine pathways.

Authors:  E Arzt
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

3.  SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.

Authors:  Lerin R Luckett-Chastain; Michael A Ihnat; Bethany M Mickle-Kawar; Randle Michael Gallucci
Journal:  J Interferon Cytokine Res       Date:  2012-02-07       Impact factor: 2.607

Review 4.  JAK-STAT pathway in carcinogenesis: is it relevant to cholangiocarcinoma progression?

Authors:  Olga V Smirnova; Tatiana Yu Ostroukhova; Roman L Bogorad
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

Review 5.  Targeted activation of astrocytes: a potential neuroprotective strategy.

Authors:  Carole Escartin; Gilles Bonvento
Journal:  Mol Neurobiol       Date:  2008-10-18       Impact factor: 5.590

Review 6.  Protein hormones and immunity.

Authors:  Keith W Kelley; Douglas A Weigent; Ron Kooijman
Journal:  Brain Behav Immun       Date:  2007-01-02       Impact factor: 7.217

7.  The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury.

Authors:  Hideo Yasukawa; Toshitaka Yajima; Hervé Duplain; Mitsuo Iwatate; Masakuni Kido; Masahiko Hoshijima; Matthew D Weitzman; Tomoyuki Nakamura; Sarah Woodard; Dingding Xiong; Akihiko Yoshimura; Kenneth R Chien; Kirk U Knowlton
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

8.  Role of the intracellular receptor domain of gp130 (exon 17) in human inflammatory bowel disease.

Authors:  Christoph-J Auernhammer; Kathrin Zitzmann; Fabian Schnitzler; Julia Seiderer; Peter Lohse; George Vlotides; Dieter Engelhardt; Michael Sackmann; Burkhard Goke; Thomas Ochsenkuhn
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

9.  Transcriptional activation of the suppressor of cytokine signaling-3 (SOCS-3) gene via STAT3 is increased in F9 REX1 (ZFP-42) knockout teratocarcinoma stem cells relative to wild-type cells.

Authors:  Juliana Xu; Renia Sylvester; Ann P Tighe; Siming Chen; Lorraine J Gudas
Journal:  J Mol Biol       Date:  2008-01-30       Impact factor: 5.469

10.  Ovarian insufficiency and early pregnancy loss induced by activation of the innate immune system.

Authors:  Adrian Erlebacher; Dorothy Zhang; Albert F Parlow; Laurie H Glimcher
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.